Organ donation from patients with a rare disease is often safe: the italian guidelines
- PMID: 35906735
- DOI: 10.1111/ctr.14769
Organ donation from patients with a rare disease is often safe: the italian guidelines
Abstract
Although a disease is defined as rare when it has a prevalence of less than 1:2000, the overall prevalence of rare diseases in the population is greater than 1%. Among potential organ donors, a similar frequency is observed. To date, guidelines have not been established, and operational decisions have been made empirically, case- by-case, based on the experience and expertise of clinicians. For this reason, the Italian Superior Health Council (CSS) has appointed a working Group to address "patients with a rare disease as potential organ donors," with the aim of devising recommendations for the management of transplant cases in which the donors have a rare disease. This group evaluated 493 diseases (10% of all rare diseases, including over 95% of patients with a rare disease) to deliver a technical report dealing with the suitability of organ donation and transplantation, with a focus on the organs most frequently used, including kidney, liver, heart, lung, and pancreas. This work has made it clear that a rare disease "per se" does not contraindicate organ donation at all. Indeed, in donors affected by a rare disease, almost 80% of the organs are suitable for transplantation, approximately 7% are unsuitable, and approximately 14% are suitable as non-standard with an acceptable risk.
Keywords: guidelines; organ donors; rare disease; risk assessment.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Solid Organ Donor Suitability Assessment Protocol, defined by the Italian law: CONFERENZA STATO-REGIONI DEL 24.01.2018: Accordo, ai sensi dell'articolo 4 del decreto legislativo 28 agosto 1997, n. 281, tra il Governo, le Regioni e le Province autonome di Trento e Bolzano sul documento recante “Protocollo per la valutazione di idoneità del donatore di organi solidi”. Repertorio Atti n: 17/CSR del 24/01/2018
-
- United States Food and Drug Administration. Orphan Drug Act. Public Law No. 97-414 96 Stat. 2049. 1983.
-
- European Parliament and the Council of the European Union. Decision No 1295/1999/EC of the European Parliament and of the Council of 29 April 1999 adopting a programme of Community action on rare diseases within the framework for action in the field of public health (1999 to 2003). 1999. Accessed August 26, 2021. http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1395750802170&uri...
-
- Richter T, Nestler-Parr S, Babela R, Khan ZM, Tesoro T, Molsen E. Rare disease terminology and definitions-a systematic global review: report of the ISPOR Rare Disease Special Interest Group. Value Health. 2015;18:906-914.
-
- Moliner AM, Waligóra J. The European Union policy in the field of rare diseases. Public Health Genomics. 2013;16:268-277.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
